Author:
Murray Michael,Fiala-Beer Eva,Sutton Dylan
Reference48 articles.
1. Combination therapy with haloperidol and ORPH in schizophrenia. A clinical and pharmacokinetic study;ALTAMURA;Encephale,1986
2. Spectral interaction of orphenadrine and its metabolites with oxidised and reduced hepatic microsomal cytochrome P-450 in the rat;BAST;Biochem. Pharmacol.,1982
3. Relationship between molecular structure and cytochrome P450-metabolic intermediate complex formation, studied with orphenadrine analogues;BAST;J. Pharm. Sci.,1984
4. Effect of multiple administration of orphenadrine or mono-N-desmethylorphenadrine on cytochrome P-450 catalyzed reactions in the rat;BAST;Arch. Toxicol.,1983a
5. Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat;BAST;Res. Commun. Chem. Pathol. Pharmacol.,1983b
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献